Chronic and Degenerative Conditions User 11 ran a progressive protocol for golfer's elbow that extended across multiple months, increasing the dose when insufficient response appeared at lower levels
[3] The same work profiled shifts in the cecal microbiome associated with treatment
However, the lack of clinical trials means that there could potentially be serious BPC-157 side effects in humans, which remain unknown
BPC-157 (Body Protection Compound-157), also designated as PL 14736, is a synthetic pentadecapeptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that was first isolated and identified from human gastric juice in the early 1990s
Research Applications & Usage Information In laboratory research, AOD 9604 (3mg) is commonly employed in controlled in-vitro and non-clinical in-vivo models
Has BPC-157 been studied in tendon cells